Abstract
S10 Safety and Efficacy of Liposomal Irinotecan as the Second-Line Treatment for Locally Advanced or Metastatic Pancreatic Cancer: A Systematic Review and Meta-Analysis of Randomized Clinical Trials and Real-World Studies
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
